Reconde SD, Peña FMÁ

Language: Spanish
References: 10
Page:
PDF size: 351.23 Kb.

ABSTRACT

Introduction: Parkinson's disease is one of the most frequent neurodegenerative diseases of the motor system that affects the quality of life of the patient.
Methods: A descriptive study was carried out, which included patients with diagnosis of Parkinson's disease, treated in the Movement Disorders Clinic of the International Center for Neurological Restoration (CIREN) from October 2018 to October 2019, sample consisted of 100 patients with Parkinson's disease.
Results: The average age was 60.21% years; the most affected group was that of 60 to 69 years old, the predominant sex was male; 38% were university students; 50% were in stage II of the Hoehn and Yarh scale; 44% were in the group of 1 to 5 years of evolution of the disease, the first symptom that appeared in the disease was tremor in 56%; 58% had sleep disorders and 51% depression; the most percent of the patients had medical treatment levodopa/carbidopa; 55% had a history of previous falls.
Conclusions: Knowing the clinical-epidemiological characteristics and the repercussion that this disease represents for the patient from the psychic, physical and social point of view will make easier its diagnosis and medical treatment.

REFERENCES

1. Cacabelos R, Parkinson’sDesease: FromPathogenesistoPharmacogenomics,Int J Mol Sci2017; 18(3): 551.

2. Castro Toro A, Freddy Buriticá O, Enfermedad de Parkinson: criterios diagnósticos, factores de riesgo y de progresión, y escalas de valoración del estadio clínico, Act Neurol Colomb2014; 30(4):300-6.

3. Preux PM, Codet A, Anglade C, Druet-Cabanac M, Debrock C, Macharia W, Couratier P, Boutros-Toni F, Dumas M, Parkinson's disease and environmental factors, Matched casecontrolstudy in the Limousin region, France, Neuroepidemiology 2000; 19(6):333-7.

4. Rey Pérez A, Enfermedad de Parkinson y otros Parkinsonism’s, Madrid: Médica Panamericana,2009.

5. Dexter D, Jenner P, Parkinson disease: from pathology to molecular disease mechanisms, Free Radic Biol Med 2013; (62):132-44.

6. Martínez Jurado E, Cervantes Arriaga A, Rodríguez Violante ,Calidad de vida en pacientes con enfermedad de Parkinson, Rev,MexNeuroci 2010; 11(6):480-86.

7. Capriotti T, Terzakis K, “Parkinson Disease,” Home Healthcare Now ,2016; 34(6): 300-7.

8. Fritsch, Thomas, Kathleen A, Smyth, Maggie S, Wallendal, Trevor Hyde, et al, “Parkinson Disease: Research Update and Clinical Management,” Southern Medical Journal2016, 105(12): 650–56.

9. Jankovic Progression of Parkinson’s disease. Are we making progress in charting the course? Arch Neurol2005; 62:351-52.

10. Giroud Benítez JL, Collado-Mesa F, Esteban EM, [Prevalence of Parkinson disease in an urban area of the Ciudad de La Habana province, Cuba,Doortodoor population Study Neurología 2000; 15(7):269-73.